Spain· ES:62250
SPIRAXIN 200 mg COMPRIMIDOS RECUBIERTOS CON PELICULA
A medicinal product containing rifaximina, registered in Spain by Alfasigma S.P.A..
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- rifaximina
- Manufacturer
- Alfasigma S.P.A.
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cima_codigo65664512EUR 9.21
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Rifaximina in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandXifaxanInPharm Sp. z o.o.
- CzechiaNORMIXAlfasigma S.p.A., Bologna
- United KingdomNormix 100mg/5ml granules for oral suspensionImported (Italy)
- FinlandReferoALFASIGMA S.p.A.
- United StatesXIFAXANA-S Medication Solutions
- NetherlandsTIXTELLER 550 mg filmomhulde tablettenAlfasigma S.p.A.
- NorwayNormixAlfa Wassermann
- SwedenXifaxan 550 mg Filmdragerad tablettMedartuum AB
Authorised across Europe · EMA
The same active substance is authorised in 20 EEA countries. Names it is sold under:
- Austria · Colidimin, Refero
- Belgium · Targaxan, Tixteller
- Czechia · Normix
- Germany · Rifaxan, Tixteller
- Denmark · Faxinorm, Xifaxan
- Finland · Targaxan, Xifaxan
- France · Tixtar
- United Kingdom (Northern Ireland) · Normicron, Rifaximin
- Greece · Rifacol
- Hungary · Normix, Refero
- Ireland · Rifaximin Alfasigma, Targaxan
- Italy · Flonorm, Normix
- Luxembourg · Refero, Targaxan
- Netherlands · Tixteller, Xifaxan
- Norway · Xifaxan
- Poland · Tixteller, Xifaxan
- Portugal · Refero, Xifaxan
- Romania · Normix, Tixteller
- Sweden · Xifaxan
- Slovakia · Normix, Refero
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0dd83fc8-1d8b-4f54-a90b-78511f73bb51 GET /v1/drugs/0dd83fc8-1d8b-4f54-a90b-78511f73bb51?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Medicamento Sujeto A Prescripción Médica",
"estado": "{\"aut\":936136800000}",
"nregistro": "62250",
"substance": "rifaximina"
}See everything about rifaximina.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.